Exceptional negative changes in fundamentals have recently occurred for WPP PLC (NYSE: WPP): significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2026 decreased significantly, and the consensus estimate […]
Neonode Inc (NASDAQ: NEON) stock suffered a major decline of -14.2% on 9/2/25. The shares closed at $20.56. Moreover, above average trading volume at 135% of normal accompanied the decline. The stock has been exceptionally […]
McEwen Mining Inc (NYSE: MUX) stock closed at $13.79 on 9/2/25 after a major increase of 19.4%. Moreover, exceptionally high trading volume at 583% of normal accompanied the advance. The stock has risen 27.0% during […]
Extremely significant negative changes in Markel Corp (NYSE: MKL) investment behavior have recently occurred: negative upside/downside volume developed, and its shorter term price trend turned down. Recent notable negative changes in fundamentals have affected Markel […]
Cytokinetics Inc (NASDAQ: CYTK) stock enjoyed a major increase of 40.4% on 9/2/25. The shares closed at $49.62. Moreover, trading volume in this advance was exceptionally high at 750% of normal. The stock has been […]
On 9/2/25, Cinedigm Corp (NASDAQ: CNVS) stock suffered a major decline of -17.2%, closing at $4.05. Moreover, trading volume in this decline was unusually high at 196% of normal. The stock has been exceptionally strong […]
Nephros Inc. (NASDAQ: NEPH) stock enjoyed a major increase of 12.6% on 9/2/25. The shares closed at $4.20. Moreover, this advance was accompanied by unusually high trading volume at 163% of normal. The stock has […]
Ionis Pharmaceuticals Inc (NASDAQ: IONS) stock closed at $57.49 on 9/2/25 after a major increase of 34.8%. Moreover, exceptionally high trading volume at 719% of normal accompanied the advance. The stock has been strong relative […]
vTv Therapeutics Inc (NASDAQ: VTVT) stock closed at $18.40 on 9/2/25 after a major increase of 13.3%. Moreover, this advance was accompanied by exceptionally high trading volume at 474% of normal. The stock has risen […]
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock closed at $25.68 on 9/2/25 after a major increase of 16.6%. Moreover, this advance was accompanied by exceptionally high trading volume at 276% of normal. The stock has risen […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research